Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Food insecurity linked to tumor growth in pediatric neuroblastoma

2.

New imaging guidelines for head and neck cancers, a step toward practice change

3.

Rural residents continue to have higher odds of skin cancer, study finds

4.

24 months after radical prostateectomy, no PSA recurrence was observed when using apalutamide plus ADT.

5.

Is Exercise an Effective Treatment for Prostate Cancer?


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot